Linkedin Facebook Contact with Pharma Industrial India
 

Last edition

September - October, 2025
All magazines
Subscribe to our magazine
autodoc
 
Home › News › Industrial talks

Cipla receives US FDA approval for generic Durezol

Cipla receives US FDA approval for generic Durezol

Cipla Limited has received final approval for its Abbreviated New Drug Application (ANDA) for difluprednate ophthalmic emulsion 0.05% from the United States Food and Drug Administration (FDA).

Cipla's difluprednate ophthalmic emulsion 0.05% is AB-rated generic therapeutic equivalent version of Novartis Pharmaceutical Corporation's Durezol.

It is used for the treatment of inflammation and pain associated with ocular surgery and treatment of endogenous anterior uveitis.

According to IQVIA (IMS Health), Durezol had US sales of approximately $106 million for the 12-month period ending June 2021.

The product will be available for shipping soon.

 

 

 

 

 

 
Read more on:
Cipla receives US FDA approval for generic Durezol US FDA approval for generic Durezol
More news about: industrial talks | Published by Darshana | August - 12 - 2021 | 179

Last news about this category

Health Minister Marks AMRIT Pharmacy's 10th Anniversary, Announces Nationwide Expansion Health Minister Marks AMRIT Pharmacy's 10th Anniversary, Announces Nationwide Expansion
Pfizer Completes Acquisition of Metsera Pfizer Completes Acquisition of Metsera
Biocon Clarifies Media Reports on Possible Biocon Biologics Merger Biocon Clarifies Media Reports on Possible Biocon Biologics Merger
US FDA Appoints Richard Pazdur as Director of CDER US FDA Appoints Richard Pazdur as Director of CDER
Biocon Posts Robust Q2FY26 Results as Biosimilars and Generics Drive Double-Digit Growth Biocon Posts Robust Q2FY26 Results as Biosimilars and Generics Drive Double-Digit Growth
Novo Nordisk Confirms No Further Proposal Increase for Metsera Acquisition Novo Nordisk Confirms No Further Proposal Increase for Metsera Acquisition
Senores Pharma Subsidiary Acquires Stake in Zoraya Pharmaceuticals Senores Pharma Subsidiary Acquires Stake in Zoraya Pharmaceuticals
PBS Biotech Appoints Martin Simonetti as CEO PBS Biotech Appoints Martin Simonetti as CEO
Helex Raises USD 3.5 Million in Seed Round to Advance Non-Viral Gene Therapies for Kidney Diseases Helex Raises USD 3.5 Million in Seed Round to Advance Non-Viral Gene Therapies for Kidney Diseases
Cipla Elevates Achin Gupta as Next Managing Director and Global CEO Cipla Elevates Achin Gupta as Next Managing Director and Global CEO
 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members

Privacy Policy | Cookies Policy